{"id":"W2084084252","doi":"10.1213/01.ane.0000048370.91644.77","title":"COX-2 Inhibition for Postoperative Analgesia","year":2003,"lang":"en","type":"letter","venue":"Anesthesia & Analgesia","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rofecoxib; Medicine; Celecoxib; Adverse effect; Relative risk; Clinical trial; Internal medicine; Randomized controlled trial; Drug class; Confidence interval; Diclofenac; Adverse Event Reporting System; Anesthesia; Drug; Pharmacology; Cyclooxygenase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004908551,0.002153191,0.002478069,0.00160502,0.001075125,0.003561108,0.003314151,0.009481785,0.007499067],"category_scores_gemma":[0.01987409,0.0007671841,0.001965512,0.001174805,0.001858825,0.003989264,0.001018168,0.01848852,0.007257018],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002132457,"about_ca_system_score_gemma":0.002925761,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00155522,"about_ca_topic_score_gemma":0.003151132,"domain_scores_codex":[0.9964221,0.0006506863,0.0006456921,0.0004985004,0.001545837,0.0002373018],"domain_scores_gemma":[0.9871049,0.004759826,0.001206964,0.0002802982,0.005640965,0.001007086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001200453,0.0000225383,0.00007863888,0.001106555,0.00005505817,0.0001733901,0.00002431386,0.00004463129,0.0001442762,0.0006651987,0.9692196,0.02834586],"study_design_scores_gemma":[0.0001574775,0.0001307362,0.000695524,0.001916746,0.0001410902,0.0008529515,0.00005414404,0.000212774,0.0003224401,0.001451245,0.9940227,0.00004205333],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"commentary","genre_scores_codex":[0.0001811586,0.06865418,0.0002923263,0.1759879,0.7532381,0.00002620152,0.0001411629,0.00006781318,0.00141117],"genre_scores_gemma":[0.001786816,0.04062828,0.0002875761,0.172373,0.7789295,0.00003534605,0.00006981238,0.00004835361,0.005841407],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.009481785,"threshold_uncertainty_score":0.02595919,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01432994872944797,"score_gpt":0.2548265985722749,"score_spread":0.2404966498428269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}